Regeneron's Regen-Cov reduces death in seronegative COVID-19 patients

Retrieved on: 2021-06-16 18:00:00

Tags for this article:

Click the tags to see associated articles and topics

Regeneron's Regen-Cov reduces death in seronegative COVID-19 patients. View article details on hiswai:

Excerpt

Zai Lab markets the PARP inhibitor Zejula (niraparib) in China after ... Triwise, Epiphron Capital, Kunlun Capital and South China Venture Capital.

Article found on: www.bioworld.com